Literature DB >> 31486373

Medical crowdfunding to access CAR T-cell therapy.

Linda D Ho1, Sarah O Oso1, Aaron D Levine2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31486373     DOI： 10.1016/S1470-2045(19)30466-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  Crowdfunding for anticancer therapies: an analysis of non-US GoFundMe pages.

Authors:  Shahid Iqbal; Dearbhaile Catherine Collins
Journal:  Ir J Med Sci       Date:  2021-01-06       Impact factor: 1.568

Review 2.  Value and affordability of CAR T-cell therapy in the United States.

Authors:  Salvatore Fiorenza; David S Ritchie; Scott D Ramsey; Cameron J Turtle; Joshua A Roth
Journal:  Bone Marrow Transplant       Date:  2020-05-30       Impact factor: 5.483

Review 3.  Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond.

Authors:  Christopher T Su; J Christine Ye
Journal:  J Hematol Oncol       Date:  2021-07-23       Impact factor: 17.388

4.  An overview of Fintech applications to solve the puzzle of health care funding: state-of-the-art in medical crowdfunding.

Authors:  Laura Grassi; Simone Fantaccini
Journal:  Financ Innov       Date:  2022-09-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.